What is PLRX's dilution risk score?

PLRX has a latest available DilutionScore record of 50/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for PLRX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for PLRX?

DilutionWatch tracks 25 SEC filing types for PLRX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect PLRX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For PLRX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for PLRX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for PLRX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

PLRX Dilution Risk Score: 50/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

90

💰 Cash Runway

40

📊 Float Risk

5

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 21%

🔄 Reverse Split model est. 30%

• 50-day avg $1.25 approaching $1 threshold

💰 Capital Raise model 20%

• Active shelf registration ($300M, 385% of market cap)

🔔 Track PLRX — Get forecast alerts →

Market Data

Market Cap$78.02M

Shares Outstanding61.92M

Float60.23M

Cash$158.10M

Debt$28.78M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 20.4% shares (2026Q1 vs prior)

93 institutional holders · 61.52M shares

#1 TANG CAPITAL MANAGEMENT LLC 6.14M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 4.69M shares

#3 MORGAN STANLEY 4.56M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.81M

Days to Cover5.7

% of Float4.7%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-12-31

EFFECT EFFECT 2026-04-06

S-3 SHELF 2026-03-30

8-K 8K EVENT 2026-03-30

4 INSIDER TRANSACTION 2026-01-26

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual PLRX Dilution Snapshot

Pliant Therapeutics, Inc. (PLRX) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $300.0M.
Recent SEC activity tracked for PLRX: EFFECT on 2026-04-06; S-3 on 2026-03-30; 8-K on 2026-03-30.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.